FDA approves new monoclonal antibody for hospitalized COVID-19 patients ...Middle East

The Hill - News
FDA approves new monoclonal antibody for hospitalized COVID-19 patients
The Food and Drug Administration (FDA) on Wednesday approved a monoclonal antibody from Roche to treat COVID-19 in hospitalized adult patients, the company announced. The drug, called Actemra, was originally approved in 2010 to treat adult patients with moderate to severe rheumatoid arthritis. The company says that is the first FDA-approved monoclonal antibody intended to treat patients with severe cases of COVID-19. "Actemra is the first FDA-approved monoclonal antibody for treating patients with severe COVID-19, providing an important option for hospitalized patients and their healthcare providers who continue to be on the frontlines treating COVID-19," Levi Garraway, Roche's chie

Hence then, the article about fda approves new monoclonal antibody for hospitalized covid 19 patients was published today ( ) and is available on The Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA approves new monoclonal antibody for hospitalized COVID-19 patients )

Apple Storegoogle play

Last updated :

Also on site :